Mezomax’s MMX is a first of its kind, oral-therapy used to repair nonhealing fractures and maintain strong bones.

Mezomax is committed to bringing this highly effective treatment to patients within the U.S. and is currently pursuing an expedited approval for the oral formulation for use in nonunion bone fractures by 2022.


Start typing and press Enter to search